John A. Kraeutler

This profile gathers the share dealings of John A. Kraeutler in Meridian Bioscience Inc. In total, 110 filings cover trades dated from 26 July 2006 to 9 November 2017.

In open-market terms, that means 3 purchases worth €228k on one side and 32 sales worth €5.6M on the other. On balance, insiders were net sellers of €5.4M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 30 share grants and 27 option exercises. In 2017 alone, the filings show 1 purchase and no sales.

Half of the purchases are above €74k and half below.

Most recently, on 13 November 2017, the filings show a share grant in Meridian Bioscience Inc. The most recent open-market purchase was published on 25 August 2017, 3,362 days ago. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.